XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities:    
Net income $ 377,440 $ 435,336
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 96,013 108,269
Stock-based compensation expense 56,575 62,276
Deferred taxes 3,256 2,294
Loss on impairment of lease related assets 35,501 0
Reduction in the carrying amount of operating lease right-of-use assets 35,366 37,261
Amortization and write-off of deferred financing fees 2,273 1,914
Gain on de-designated swaps (40,547) (11,751)
Changes in assets and liabilities:    
Fees receivable, net 159,098 132,650
Deferred commissions 60,156 10,494
Prepaid expenses and other current assets (20,248) (822)
Other assets 11,317 (23,769)
Deferred revenues 212,083 190,814
Accounts payable and accrued and other liabilities (404,891) (212,321)
Cash provided by operating activities 583,392 732,645
Investing activities:    
Additions to property, equipment and leasehold improvements (38,385) (24,479)
Acquisitions - cash paid (net of cash acquired) 0 (22,774)
Cash used in investing activities (38,385) (47,253)
Financing activities:    
Proceeds from employee stock purchase plan 11,995 9,414
Proceeds from borrowings 0 600,000
Payments of deferred financing fees 0 (6,045)
Payments on revolving credit facility 0 (5,000)
Payments on borrowings (2,663) (105,256)
Purchases of treasury stock (929,880) (1,083,350)
Cash used in financing activities (920,548) (590,237)
Net (decrease) increase in cash and cash equivalents and restricted cash (375,541) 95,155
Effects of exchange rates on cash and cash equivalents (20,479) (7,281)
Cash and cash equivalents and restricted cash, beginning of period 760,602 712,583
Cash and cash equivalents and restricted cash, end of period $ 364,582 $ 800,457